Physician profile
Thomas Freeman
NPI 1063947406
$2,860.90
in general payments reported to CMS, 2019-2025
10 companies · $2,594 in 2025
The $2,594 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $151 · 2024: $115 · 2025: $2,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,442 · Food and Beverage: $1,380 · Gift: $39.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,441.84 |
| Food and Beverage | $1,379.57 |
| Gift | $39.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $2,464.80 | 2024-2025 | Inset System |
| Catalyst Orthoscience | $118.75 | 2025 | |
| Vericel Corporation | $109.82 | 2023 | Maci |
| Smith+Nephew, INC. | $41.41 | 2023 | Ultrabutton |
| Zak Ortho | $24.64 | 2025 | |
| Boston Scientific Corporation | $24.27 | 2025 | Wavewriter Alpha Prime 16 |
| Vertex Pharmaceuticals Incorporated | $23.43 | 2025 | |
| Zimvie INC. | $20.95 | 2024 | |
| Novo Nordisk INC | $19.65 | 2025 | |
| Lightbody Medical Technologies INC | $13.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.